                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
<120>  RETROVIRAL VECTOR PACKAGING CELL LINES AND METHODS OF PURIFYING 
       AND PRODUCING RETROVIRAL PARTICLES

<130>  715813

<150>  US 61/759,516
<151>  2013-02-01

<160>  21    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Gibbon Ape Leukemia Virus

<400>  1

Asp Arg Ile Ser Ala Val Lys Ile Leu 
1               5                   


<210>  2
<211>  10
<212>  PRT
<213>  Gibbon Ape Leukemia Virus

<400>  2

Val Leu Arg Gln Lys Ala Leu Glu Asn Glu 
1               5                   10  


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3

Asp Arg Ile Ser Ala Val Gln Ala Leu 
1               5                   


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4

Val Leu Thr Gln Lys Ala Leu Glu Asn Glu 
1               5                   10  


<210>  5
<211>  5
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  5

Met Gly Pro Asn Leu 
1               5   


<210>  6
<211>  18
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  6

Gln Val Met Thr Ile Thr Pro Pro Gln Ala Met Gly Pro Asn Leu Val 
1               5                   10                  15      


Leu Pro 
        


<210>  7
<211>  7
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  7

Ala Met Gly Pro Asn Leu Val 
1               5           


<210>  8
<211>  9
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  8

Gln Ala Met Gly Pro Asn Leu Val Leu 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  9

Ala Met Gly Pro Asn Leu Val Leu Pro 
1               5                   


<210>  10
<211>  8
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  10

Gln Ala Met Gly Pro Asn Leu Val 
1               5               


<210>  11
<211>  8
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  11

Ala Met Gly Pro Asn Leu Val Leu 
1               5               


<210>  12
<211>  11
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  12

Pro Gln Ala Met Gly Pro Asn Leu Val Leu Pro 
1               5                   10      


<210>  13
<211>  10
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  13

Gln Ala Met Gly Pro Asn Leu Val Leu Pro 
1               5                   10  


<210>  14
<211>  10
<212>  PRT
<213>  Feline leukemia virus (FeLV) subgroup B

<400>  14

Pro Gln Ala Met Gly Pro Asn Leu Val Leu 
1               5                   10  


<210>  15
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  15

Gly Lys Pro Ile Pro Asn Pro Leu Leu Gly Leu Asp Ser Thr 
1               5                   10                  


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  16

Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   


<210>  17
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  17

Tyr Pro Tyr Asp Val Pro Asp Tyr Ala Tyr Pro Tyr Asp Val Pro Asp 
1               5                   10                  15      


Tyr Ala 
        


<210>  18
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  18

Gly Lys Pro Ile Pro Asn Pro Leu Leu Gly Leu Asp Ser Thr Gly Lys 
1               5                   10                  15      


Pro Ile Pro Asn Pro Leu Leu Gly Leu Asp Ser Thr 
            20                  25              


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  19

Met Gly Pro Asn Leu Met Gly Pro Asn Leu 
1               5                   10  


<210>  20
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  20

Met Leu Leu Thr Ser Asn Leu His His Leu Arg His Gln Met Ser Pro 
1               5                   10                  15      


Gly Ser Trp Lys Arg Leu Ile Ile Leu Leu Ser Cys Val Phe Gly Gly 
            20                  25                  30          


Gly Gly Thr 
        35  


<210>  21
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  21

Ser Leu Gln Asn Lys Asn Pro His Gln Pro Met Thr Leu Thr Trp Gln 
1               5                   10                  15      


Val Leu Ser Gln Thr Gly Asp Val Val Trp Asp Thr Lys Ala Val Gln 
            20                  25                  30          


